Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Shanghai Kou Qiang Yi Xue ; 31(4): 418-422, 2022 Aug.
Artigo em Chinês | MEDLINE | ID: mdl-36710558

RESUMO

PURPOSE: To evaluate the clinical benefits of Er:YAG laser combined with guided bone regeneration (GBR) in the treatment of peri-implantitis-assocaited osseous defects. METHODS: Twenty-six patients (34 implants in total) who underwent implant restoration in Dental Disease Prevention and Treatment Institute, Jiading District, from 2017 to 2019 and were diagnosed with peri-implantitis with osseous defects, and randomly divided into the experimental group and control group. The two groups of patients received open flap surgery, debridement and GBR treatment. The only difference in the experimental group was the use of Er: YAG laser to modulate and remove inflammatory tissue as well as to decontaminate the implant surface, instead of traditional mechanical treatment in the control group. The probing depth (PD), bleeding on probing (BOP), and plaque index (PI), the height of the bone defect around the implant (reduce of marginal bone level, RBL) were recorded and compared. SPSS 20.0 software package was used to analyze the data. RESULTS: The PD, BOP, PI and RBL of the two groups of patients were significantly improved after treatment with different methods. There was no significant difference in the improvement of PD, BOP and PI between the two groups 6, 12 and 24 months after treatment, while the improvement of RBL in the experimental group was significantly better than that of the control group 12 and 24 months after treatment. CONCLUSIONS: In the treatment of GBR with peri-implantitis and osseous defects, Er: YAG laser therapy is more effective than traditional mechanical methods, and is more conducive to the regeneration of new bone.


Assuntos
Terapia a Laser , Lasers de Estado Sólido , Peri-Implantite , Humanos , Desbridamento/métodos , Implantes Dentários/efeitos adversos , Lasers de Estado Sólido/uso terapêutico , Terapia com Luz de Baixa Intensidade , Peri-Implantite/cirurgia
2.
J Immunol ; 173(6): 4207-17, 2004 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-15356172

RESUMO

NF-kappaB is a central transcriptional factor and a pleiotropic regulator of many genes involved in immunological responses. During the screening of a plant extract library of traditional Chinese herbal medicines, we found that NF-kappaB activity was potently inhibited by andrographolide (Andro), an abundant component of the plant Andrographis that has been commonly used as a folk remedy for alleviation of inflammatory disorders in Asia for millennia. Mechanistically, it formed a covalent adduct with reduced cysteine (62) of p50, thus blocking the binding of NF-kappaB oligonucleotide to nuclear proteins. Andro suppressed the activation of NF-kappaB in stimulated endothelial cells, which reduced the expression of cell adhesion molecule E-selectin and prevented E-selectin-mediated leukocyte adhesion under flow. It also abrogated the cytokine- and endotoxin-induced peritoneal deposition of neutrophils, attenuated septic shock, and prevented allergic lung inflammation in vivo. Notably, it had no suppressive effect on IkappaBalpha degradation, p50 and p65 nuclear translocation, or cell growth rates. Our results thus reveal a unique pharmacological mechanism of Andro's protective anti-inflammatory actions.


Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Cisteína/metabolismo , Diterpenos/farmacologia , Medicamentos de Ervas Chinesas/farmacologia , NF-kappa B/antagonistas & inibidores , NF-kappa B/metabolismo , Transporte Ativo do Núcleo Celular/efeitos dos fármacos , Animais , Anti-Inflamatórios não Esteroides/isolamento & purificação , Ligação Competitiva/efeitos dos fármacos , Adesão Celular/efeitos dos fármacos , Linhagem Celular , Núcleo Celular/efeitos dos fármacos , Núcleo Celular/metabolismo , Diterpenos/isolamento & purificação , Diterpenos/metabolismo , Avaliação Pré-Clínica de Medicamentos , Medicamentos de Ervas Chinesas/isolamento & purificação , Medicamentos de Ervas Chinesas/metabolismo , Selectina E/biossíntese , Selectina E/metabolismo , Endotélio Vascular/citologia , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/metabolismo , Inibidores do Crescimento/farmacologia , Células HL-60 , Humanos , Hipersensibilidade/patologia , Hipersensibilidade/prevenção & controle , Proteínas I-kappa B/antagonistas & inibidores , Proteínas I-kappa B/metabolismo , Leucócitos/efeitos dos fármacos , Leucócitos/metabolismo , Leucócitos/patologia , Pulmão/efeitos dos fármacos , Pulmão/patologia , Camundongos , Camundongos Endogâmicos BALB C , Inibidor de NF-kappaB alfa , NF-kappa B/genética , Subunidade p50 de NF-kappa B , Células NIH 3T3 , Infiltração de Neutrófilos/efeitos dos fármacos , Sondas de Oligonucleotídeos/antagonistas & inibidores , Sondas de Oligonucleotídeos/metabolismo , Oxirredução , Peritonite/patologia , Peritonite/prevenção & controle , Ligação Proteica/efeitos dos fármacos , Choque Séptico/prevenção & controle , Fator de Transcrição RelA
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA